Article
Suppression of CCT3 inhibits malignant proliferation of human papillary thyroid carcinoma cell
13 Apr 2018
Abstract excerpt
Papillary thyroid carcinoma (PTC) is the most frequently occurring subtype of thyroid cancer. A certain portion of PTCs can progress to recurrent metastatic cancer. Currently, there remains no effective molecular target therapy for PTCs. As a subunit of the chaperonin containing TCP1 (CCT) complex, CCT3 is involved in various biological processes. CCT3 has been reported to drive the proliferation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
